Safety results from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or withoutbevacizumab (B) in patients (pts) with gastric or type II/III oesophagogastric junction (OGJ)adenocarcinoma

A Okines, Ruth Langely, LC Thompson, SP Stenning, L Stevenson, S Falk, MT Seymour, FY Coxon, Gary Middleton, D Smith, L Evans, S Slater, JS Water, D Ford, M Hall, Tim Iveson, Russell David Petty, C Plummer, W Alum, David Cunningham

Research output: Contribution to journalArticle

Original languageEnglish
Article number4092
JournalJournal of Clinical Oncology
Volume29
Issue numberSuppl.
Publication statusPublished - 2011

Cite this